SLC30A10 and extrahepatic bile duct carcinoma: To our knowledge, SLC30A10 Thr95Ile would be the strongest genetic cholangiocarcinoma risk factor identified to date, being carried by 5% of the extrahepatic bile duct cancer cases in the White British subset of the biobank.